The flagship Inogen One G4 provides a single-solution portable oxygen concentrator (POC), while the Inogen At Home is designed for patients requiring oxygen therapy during sleep. In October ...

Inogen shows solid B2B growth, but guidance and margin issues hurt sentiment. Learn why INGN stock is a speculative play with long-term growth potential.

One of the biggest stories of last week was how Inogen, Inc. ( NASDAQ:INGN ) shares plunged 23% in the week since its... Inogen ( NASDAQ:INGN ) Full Year 2024 Results Key Financial Results Revenue ...

Inogen, Inc. INGN is well-poised for growth ... Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is among the most innovative financial ...

While Inogen has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one ...

Inogen beat Q4 earnings and revenue estimates, citing strong B2B demand. Analysts see potential but flag supply challenges and restructuring risks. Inogen, Inc. (NASDAQ: INGN) is well-poised for ...

16:31 EST Inogen (INGN) sees Q1 revenue $79M-$81M, one estimate $78.1M See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze, and streamline your search for ...

Inogen posted a Q4 adjusted EPS loss of $0.24, beating estimates, with sales reaching $80.1 million versus the $73.9 million consensus. The company expects FY25 revenue of $352 million-$355 ...

In a report released today, Michael Matson from Needham maintained a Hold rating on Inogen (INGN – Research Report). The company’s shares closed yesterday at $9.52. See what stocks are ...